CD274 and sarcopenia: In these previous reports, muscle loss (sarcopenia) was defined solely by the muscle mass observed in CT scans at a single point before treatment and suggested that the therapeutic effect of PD-1/PD-L1 inhibitors was significantly lower in the sarcopenia group [19,21,26].